On World Liver Day, Global Marketing Services Highlights Its Role as a Leading Solution Provider for Advancing Hepatitis C Care in Pakistan with Hologic’s Aptima® HCV Quant Dx Assay”

With nearly 6% of Pakistan’s population actively infected with Hepatitis C, the burden on individuals, families, and the healthcare system is staggering. But change begins with the right solution and the courage to demand more from diagnostics. At Global Marketing Services, Pakistan, we believe Pakistan deserves the most advanced solutions in healthcare. That’s why we’re proud to bring the Hologic, Inc. Aptima® HCV Quant Dx Assay to the country: a breakthrough in accurate, early detection and viral load monitoring for HCV. This test doesn’t just diagnose active infection; it empowers clinicians to track the virus with unmatched precision, even at the lowest levels, across all major HCV genotypes. Accurate diagnosis, broad genotype coverage (1–6), and ultra-sensitive viral load monitoring; all on the fully automated Panther® system for faster, high-throughput results. Introducing Aptima means advancing towards a smarter, faster healthcare system where early detection becomes the standard for every Pakistani.